Subject of the day
ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.26B | +16.8% | |
| Gross profit | $822.04M | +14.8% | |
| Operating income | $22.82M | -3.6% | |
| Net income | $732.00K | -30.7% | |
| Cash from ops | $179.85M | +9.1% |
$183.11
▲ +3.77 (+2.1%)
| 52w hi | $184.56 |
|---|---|
| 52w lo | $111.90 |
| Vol | 182.63K |
| As of | Aug 13 |
Our score +0.24
| Short | +0.33 |
|---|---|
| Medium | +0.36 |
| Long | -0.20 |
computed 2026-08-13
ICU Medical, Inc.
Healthcare · Medical Instruments & Supplies
| Market cap | $4.58B |
|---|---|
| Enterprise value | $5.47B |
| Trailing P/E | 155.18x |
| Forward P/E | 18.98x |
| EV / EBITDA | 15.85x |
| P / S (ttm) | 2.12x |
| Profit margin | 1.4% |
| Return on equity | 1.4% |
| Revenue growth | +0.5% |
| Earnings growth | -46.9% |
| Debt / equity | 59.82 |
| Beta vs SPX | 1.06 |
|---|---|
| Corr SPX | 0.45 |
| Annual vol | 38.4% |
| Annual ret | +16.9% |
| Sharpe | 0.44 |
| Max DD | -41.2% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.03 | |
| Sector | +0.12 | |
| Technical | +0.23 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $180.22 | $183.37 | $178.79 | $183.11 | 182.63K |
| Aug 12 | $180.31 | $181.05 | $177.02 | $179.34 | 314.10K |
| Aug 11 | $182.42 | $185.30 | $181.62 | $182.08 | 250.30K |
| Aug 10 | $182.67 | $186.17 | $180.89 | $182.42 | 476.90K |
| Aug 7 | $182.35 | $192.85 | $180.88 | $184.56 | 931.20K |